Orphan Drugs Market to Reach USD 340.84 Billion with 10.5% CAGR by 2027; Increasing Number of Regulatory Approvals will Contribute to Market Growth, says Fortune Business Insights™

    NEXT STORY
    Medicenna Presents Promising Preclinical Data on IL-2 and IL-13 Superkines at the EORTC-NCI-AACR Annual Meeting
    PREV STORY
    PCI Biotech: First patient enrolled in Asia in the fimaCHEM pivotal RELEASE study
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Immuron Approved to Commence Clinical Study in C.Difficile Infection (CDI)

    Key Highlights Final approval for key first in-human Clinical Study for CDI treatment, by ...

    author_avatar
    NASDAQ Market News

    TG Therapeutics Announces Positive Data from Phase 3 GENUINE Trial of TG-1101 in Combination with Ibrutinib in Patients with High Risk Chronic Lymphocytic Leukemia at the 53rd Annual Meeting of the American Society of Clinical Oncology

    Study met its primary endpoint with TG-1101 (ublituximab) plus ibrutinib increasing Overall Response Rate ...

    author_avatar
    NASDAQ Market News

    New Imaging Test Could Detect Heart Damage in Breast Cancer Patients Receiving Chemotherapy

    OTTAWA, Aug. 21, 2017 (GLOBE NEWSWIRE) -- Heart damage (cardiotoxicity) is a known risk ...

    author_avatar
    NASDAQ Market News